Fort Baker Capital Management LP Bristol Myers Squibb CO Transaction History

Fort Baker Capital Management LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $1.78 Million - $1.97 Million	-40,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $1.8 Million - $2.15 Million	40,000 New	40,000 $1.91 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fort Baker Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Fort Baker Capital Management LP with notifications on news.